Trending Now
Time Again for Covid Stocks? (LAKE, ALST, APT, DGX)
With EU virus data picking back up and a number of major international companies beginning to warn about Covid-19 second-wave effects, investors need to...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
PDS Biotechnology Corporation’s (NASDAQ: PDS) VERSATILE-002 Study in advanced HPV-related Head...
PDS Biotechnology Corporation (NASDA: PDS) has announced that its VERSATILE-002 second phase study of advanced human papillomavirus (HPV)-related head and neck cancer treatment attained...
MAKE IT MODERN
LATEST REVIEWS
NRx Pharmaceuticals (NASDAQ: NRXP) and MannKind Corporation (NASDAQ: MNKD) Enter Agreement...
NRx Pharmaceuticals (NASDAQ: NRXP) has entered an agreement with MannKind Corporation (NASDAQ: MNKD) for ZYESAMI (aviptadil) dry powder formulation development.
MannKind’s Technosphere platform to develop...
MAKE IT MODERN
PERFORMANCE TRAINING
Mustang Bio Inc. (NASDAQ:MBIO) Receives Orphan Drug Designation For MB-207 in Treating XSCID patients
Mustang Bio Inc. (NASDAQ:MBIO) has been awarded Orphan Drug Designation for MB-207, its lentiviral gene therapy for treating patients with X-linked severe combined immunodeficiency...
Heat Biologics Inc. (NASDAQ:HTBX) Regains Its Continued Listing on the NASDAQ Stock Market
Heat Biologics Inc. (NASDAQ:HTBX) has regained its listing on the Nasdaq Stock Market. This was confirmed through a letter from the Listing Qualifications Department...
Menlo Therapeutics Inc (NASDAQ:MNLO) Reports Positive Data From Phase 2 Clinical Study Of FCD...
Menlo Therapeutics Inc (NASDAQ:MNLO) achieved a breakthrough to cure moderate to severe acne vulgaris. It is evident from positive data reported in Phase 2...
Ibio Inc. (NYSEAMERICAN:IBIO) obtains an Exclusive Worldwide License to Planet’s COVID-19 Therapeutic Candidate, ACE2-Fc
The emergence of the COVID-19 pandemic caught the world by surprise, including the pharmaceutical industry. Given that coronavirus is transmitted directly or indirectly, there...
Revance Therapeutics Inc (NASDAQ:RVNC) surges while rest of the Wall Street Fizzles
Revance Therapeutics Inc (NASDAQ:RVNC) managed to gain 5.18% while Dow tumbled 500 points on Friday to end September down nearly 9%.
MAKE IT MODERN
